Foreign Filer Report • Apr 24, 2018
Preview not available for this file type.
Download Source File6-K 1 dp89892_6k.htm FORM 6-K Licensed to: ZKG Document created using EDGARfilings PROfile 4.3.3.3 Copyright 1995 - 2018 Broadridge
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of April 2018
Commission File Number: 001-13742
ISRAEL CHEMICALS LTD.
(Exact name of registrant as specified in its charter)
Israel Chemicals Ltd.
Millennium Tower
23 Aranha Street
P.O. Box 20245
Tel Aviv, 61202 Israel
(972-3) 684-4400
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F X Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes No X
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes No X
ISRAEL CHEMICALS LTD.
INCORPORATION BY REFERENCE
This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
ISRAEL CHEMICALS LTD.
Item 1
Results of the Extraordinary General Meeting of shareholders
Further to the notice of the Extraordinary General Meeting of the Shareholders dated March 7, 2018 (reference number 2018-02-021949), the Company hereby reports that all items on the agenda of the Extraordinary General Meeting that was held today, were approved:
(1) Compensation terms and an annual Equity Grant, for our new Chief Executive Officer, Mr. Raviv Zoller;
(2) Special Bonus to our Executive Chairman of the Board, Mr. Johanan Locker;
(3) Renewal of the Management Services Agreement with Israel Corporation Ltd.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| /s/ Kobi Altman | |
|---|---|
| Name: | Kobi Altman |
| Title: | Chief Financial Officer |
| /s/ Lisa Haimovitz | |
|---|---|
| Name: | Lisa Haimovitz |
| Title: | Senior Vice President, Global General Counsel and Corporate Secretary |
Date: April 24, 2018
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.